Review
Epstein-Barr virus and the B cell: that's all it takes

https://doi.org/10.1016/S0966-842X(96)90020-7Get rights and content

Abstract

Recent experiments demonstrate that a much broader range of B cells harbor-Epstein-Barr virus (EBV) in vivo than was previously expected from in vitro studies. In this review it is argued that EBV persists in vivo by integrating its biology with that of the normal B cells within which it resides, and that the B cell provides all the environments necessary for EBV to maintain its life cycle.

References (27)

  • I. Anagnostopoulos

    Blood

    (1995)
  • E.M. Miyashita

    Cell

    (1995)
  • M.G. Masucci et al.

    Trends Microbiol.

    (1994)
  • C.L. Miller

    Immunity

    (1995)
  • G. Mosialos

    Cell

    (1995)
  • G. Klein

    Cell

    (1994)
  • G. Miller
  • J.W. Gratama
  • F. Chen

    J. Virol.

    (1995)
  • L. Qu et al.

    J. Virol.

    (1992)
  • R.J. Tierney

    J. Virol.

    (1994)
  • Q.Y. Yao

    Int. J. Cancer

    (1985)
  • D.A. Thorley-Lawson et al.

    J. Exp. Med.

    (1985)
  • Cited by (106)

    • Epstein-Barr virus: Current questions and challenges

      2021, Tumour Virus Research
      Citation Excerpt :

      Latency III infection also occurs in post-transplant lymphoproliferative disease (PTLD) and AIDS-associated diffuse large B-cell lymphoma. Subsequent analyses of EBV-infected B cells in healthy individuals indicated that all of these latency forms exist in the normal course of EBV infection, although latency III occurs very transiently due to immune pressure [3–5]. In addition, a prevalent form of latency, termed latency 0, was detected in resting memory B cells, in which none of the latency proteins were expressed.

    • The mTOR inhibitor manassantin B reveals a crucial role of mTORC2 signaling in Epstein-Barr virus reactivation

      2020, Journal of Biological Chemistry
      Citation Excerpt :

      Like other herpesviruses, the EBV life cycle consists of two phases, latent and lytic. When EBV infects memory B-lymphocytes, it establishes latent infection by default and expresses a few latent genes to maintain latent infection (3, 4). Establishment of latency is a viral strategy to avoid host immune surveillance for lifetime-persistent infection.

    • Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line

      2008, Cancer Genetics and Cytogenetics
      Citation Excerpt :

      This virus infects both the B cells and epithelial cells that usually result in latent infection [2]. After primary infection, latency can be disrupted by physiological changes [3] or by exposure to certain compounds, such as 12-O-tetradecanoylphorbol-13-acetate (TPA) [4], sodium n-butyrate (SB) [5,6], and calcium ionophores [7]. TPA is the major constituent of purging croton (Croton tiglium L.), a plant native to Southeast Asia; croton oil is used in herbal medicine.

    View all citing articles on Scopus

    Tel: + 1 617 6726, fax: +1 617 636 8590

    View full text